Business Wire - Dr. Reddy’s launches authorized generic versions of Proscar® and Zocor
Tokyo, May 30, 2006 - (JCN) - On May 29, Banyu Pharmaceutical announced that the results of its recent trial of Propecia, an agent for the treatment of androgenetic alopecia (AGA), have been published in the May 16 issue of Japanese Journal of Clinical Dermatology, an academic dermatology journal.
Related Results
Testosterone doesn’t significantly improve cognition, study finds.
PRODUCT NEWS
Sporting digest: Water polo
Health: A Question of Health
Predictors of acute urinary retention in men
According to the journal, the company has confirmed the safety and efficacy of Propecia Tablet 1mg in a 3-year administration. Propecia (finasteride), which was developed by Merck & Co., is indicated for the treatment of male pattern hair loss on the vertex and anterior mid-scalp area.
c 2006 Japan Corporate News Network. All rights reserved.
Provided by ProQuest Information and Learning Company. All rights Reserved.